REYNOLDS THOMAS R

Administrateur chez Inhibitor Therapeutics, Inc. · enregistré depuis Feb 8, 2006
Senior Vice President/Secretar chez Inhibitor Therapeutics, Inc. · enregistré depuis Jan 4, 2005

Opérations d’initié de REYNOLDS THOMAS R

Transactions enregistrées: 25; depuis Jul 30, 2003

Achats sur le marché: 0

Ventes sur le marché: 7; $354.4K

Sociétés négociées: 1; dernière déclaration Jan 6, 2009

Chiffres calculés à partir des déclarations réglementaires officielles — .

Sociétés où REYNOLDS THOMAS R a négocié

Inhibitor Therapeutics, Inc.25 tx · $477.2K · Jan 6, 2009

Historique de performance de REYNOLDS THOMAS R

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de REYNOLDS THOMAS R

Co-initiés de REYNOLDS THOMAS R

BRENNAN JAMES HInhibitor Therapeutics, Inc.
CAUSEY JAMES DInhibitor Therapeutics, Inc.
Cross StefanInhibitor Therapeutics, Inc.
DOWNS L MCCARTHY IIIInhibitor Therapeutics, Inc.
D'Sylva PaulInhibitor Therapeutics, Inc.
EINSELEN PETER CInhibitor Therapeutics, Inc.
FREER RICHARD JInhibitor Therapeutics, Inc.
HARRIS ROBERT BInhibitor Therapeutics, Inc.
Hasara Garrison J.Inhibitor Therapeutics, Inc.
HedgePath, LLCInhibitor Therapeutics, Inc.
Jerman Michael AllenInhibitor Therapeutics, Inc.
Krueger Gerald PInhibitor Therapeutics, Inc.
MAGRAB E. BRENDANInhibitor Therapeutics, Inc.
Martin Robert DanielInhibitor Therapeutics, Inc.
Mayne Pharma Group LtdInhibitor Therapeutics, Inc.
Mayne Pharma International Pty LtdInhibitor Therapeutics, Inc.
Mayne Pharma Ventures Pty LtdInhibitor Therapeutics, Inc.
MCAFEE DONALD AInhibitor Therapeutics, Inc.
MCNULTY JAMES AInhibitor Therapeutics, Inc.
ODONNELL FRANCIS E JRInhibitor Therapeutics, Inc.
Ono Richard DanaInhibitor Therapeutics, Inc.
OSMAN RONALD EInhibitor Therapeutics, Inc.
Peattie DebraInhibitor Therapeutics, Inc.
PharmAust Chemistry Ltd.Inhibitor Therapeutics, Inc.
Ronald E Osman Irrevocable Trust IIIInhibitor Therapeutics, Inc.
SEARS SAMUEL P JRInhibitor Therapeutics, Inc.
Vasisht NirajInhibitor Therapeutics, Inc.
VIRCA NICHOLAS JInhibitor Therapeutics, Inc.

Cette page reprend des déclarations réglementaires publiques.

Société	Déclarée	Type	Qté	Prix	Valeur · USD	Src
Inhibitor Therapeutics, Inc.	Jan 6, 2009	Attribution	25,000	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Apr 17, 2008	Vente	-4,000	2.89	$11.6K	SEC
Inhibitor Therapeutics, Inc.	Mar 10, 2008	Attribution	1,315	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Feb 6, 2008	AttributionD (dérivé)	30,000	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Jan 3, 2007	Attribution	1,314	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Feb 8, 2006	Attribution	1,314	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Feb 8, 2006	AttributionD (dérivé)	3,943	4.80	$18.9K	SEC
Inhibitor Therapeutics, Inc.	Feb 10, 2005	AttributionD (dérivé)	20,000	—	—	SEC
Inhibitor Therapeutics, Inc.	Jan 4, 2005	AttributionD (dérivé)	10,000	6.00 USD	$60K	SEC
Inhibitor Therapeutics, Inc.	Apr 6, 2004	ExerciceD (dérivé)	-10,000	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Apr 6, 2004	Exercice	10,000	3.85 USD	$38.5K	SEC
Inhibitor Therapeutics, Inc.	Apr 6, 2004	Vente	-10,000	10.02 USD	$100.2K	SEC
Inhibitor Therapeutics, Inc.	Mar 25, 2004	ExerciceD (dérivé)	-1,400	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 25, 2004	Vente	-1,400	7.10 USD	$9.9K	SEC
Inhibitor Therapeutics, Inc.	Mar 25, 2004	Exercice	1,400	3.85 USD	$5.4K	SEC
Inhibitor Therapeutics, Inc.	Mar 23, 2004	AttributionD (dérivé)	10,000	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	Vente	-26,309	6.87 USD	$180.7K	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	ExerciceD (dérivé)	-26,309	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	ExerciceD (dérivé)	-6,141	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	Exercice	26,309	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	Vente	-6,141	6.87 USD	$42.2K	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	Exercice	6,141	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Nov 17, 2003	AttributionD (dérivé)	10,000	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Jul 30, 2003	Vente	-2,100	3.21 USD	$6.7K	SEC
Inhibitor Therapeutics, Inc.	Jul 30, 2003	Vente	-900	3.32 USD	$3K	SEC

Société	Déclarée	Type	Qté	Prix	Valeur · USD	Src
Inhibitor Therapeutics, Inc.	Jan 6, 2009	Attribution	25,000	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Apr 17, 2008	Vente	-4,000	2.89	$11.6K	SEC
Inhibitor Therapeutics, Inc.	Mar 10, 2008	Attribution	1,315	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Feb 6, 2008	AttributionD (dérivé)	30,000	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Jan 3, 2007	Attribution	1,314	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Feb 8, 2006	Attribution	1,314	0.00	—	SEC
Inhibitor Therapeutics, Inc.	Feb 8, 2006	AttributionD (dérivé)	3,943	4.80	$18.9K	SEC
Inhibitor Therapeutics, Inc.	Feb 10, 2005	AttributionD (dérivé)	20,000	—	—	SEC
Inhibitor Therapeutics, Inc.	Jan 4, 2005	AttributionD (dérivé)	10,000	6.00 USD	$60K	SEC
Inhibitor Therapeutics, Inc.	Apr 6, 2004	ExerciceD (dérivé)	-10,000	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Apr 6, 2004	Exercice	10,000	3.85 USD	$38.5K	SEC
Inhibitor Therapeutics, Inc.	Apr 6, 2004	Vente	-10,000	10.02 USD	$100.2K	SEC
Inhibitor Therapeutics, Inc.	Mar 25, 2004	ExerciceD (dérivé)	-1,400	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 25, 2004	Vente	-1,400	7.10 USD	$9.9K	SEC
Inhibitor Therapeutics, Inc.	Mar 25, 2004	Exercice	1,400	3.85 USD	$5.4K	SEC
Inhibitor Therapeutics, Inc.	Mar 23, 2004	AttributionD (dérivé)	10,000	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	Vente	-26,309	6.87 USD	$180.7K	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	ExerciceD (dérivé)	-26,309	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	ExerciceD (dérivé)	-6,141	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	Exercice	26,309	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	Vente	-6,141	6.87 USD	$42.2K	SEC
Inhibitor Therapeutics, Inc.	Mar 15, 2004	Exercice	6,141	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Nov 17, 2003	AttributionD (dérivé)	10,000	0.00 USD	—	SEC
Inhibitor Therapeutics, Inc.	Jul 30, 2003	Vente	-2,100	3.21 USD	$6.7K	SEC
Inhibitor Therapeutics, Inc.	Jul 30, 2003	Vente	-900	3.32 USD	$3K	SEC